Abstract:Favipiravir, also known as T-705, is an antiviral prodrug that was first developed against the influenza virus and was later found to be effective against other RNA viruses, including arenaviruses, bunyaviruses, Zika, Ebola, Lassa, and COVID-19 viruses, in addition to influenza A and B. Due to the global prevalence of SARS-COV-2 in 2019, Favipiravir was used as an antiviral drug for treating COVID-19, but the challenges facing it, including its solubility, tablet ability, and bioavailability, remain. It is critical and challenging to develop a drug with appropriate bioavailability, improved oral absorption, and increased solubility without interfering with other functions and preventing the consumption of high daily doses. For this purpose, in the present study, the interactions of Favipiravir-Favipiravir and Favipiravir-H 2 O and the association of the Favipiravir molecules were investigated experimentally and theoretically. The theoretical results showed that under normal conditions, all structures were stable, but the most stable structure based on calculations of electronic energy, Gibbs, and solvation Gibbs free energies (minimum value), both in the gas phase and in the aqueous phase, is related to the B-enol isomer. Also, the change in dipole moment in the solvation process for this isomer was less than others. Also, the intense intermolecular hydrogen bonds O-H...O and N-H...O between the Favipiravir and water molecules showed that Favipiravir...Favipiravir interactions are stronger than Favipiravir...H 2 O interactions in aqueous solutions. These interactions indicate that Favipiravir can participate in the aggregation phenomena in high concentrations. Also, Stoke's shift values slightly increased with the decreasing the drug concentration in water (intramolecular charge transfer phenomenon).

Synthesis of Favipiravir

Improved process for the synthesis of telaprevir

Favipiravir – a Modern Antiviral Drug: Synthesis and Modifications

Tautomerism and Rotamerism of Favipiravir and Halogenated Analogues in Solution and in the Solid State

Synthesis of Nevirapine

Structural flexibility of favipiravir and its structural analogues in solutions: experimental and computational insight

Experimental and theoretical study of the Favipiravir association in water solvent

A New Method to Synthesize Famciclovir

Spectroscopic characterization and quantum chemical calculations on Favipiravir-Guanine biomolecular complex

Quantitative Analysis of Favipiravir by HPLC: Development and Validation

Concise Synthesis of Zanamivir and Its C4-thiocarbamido Derivatives Utilizing a [3+2]-Cycloadduct Derived from D-Glucono-δ-lactone

Chemical Synthesis of the Anti‐COVID‐19 Drug Remdesivir

“One-Pot” Synthesis of Molnupiravir from Cytidine

Synthesis of Remdesivir by Direct Lithiation of Pyrrolo[2,1‐f][1,2,4]triazine Derivatives Enabled C‐Glycosylation

Synthesis of 10,10′-bis(trifluoromethyl) marinopyrrole A derivatives and evaluation of their antiviral activities in vitro

Pharmacogenomic Studies of Antiviral Drug Favipiravir

A new synthesis of the amine fragment: an important intermediate to the anti-HIV drug lenacapavir

Synthesis of cidofovir

Synthesis of an Anti-Aids Drug Delavirdine Derivate, Resdelasu

Synthesis of Revaprazan

Identification of Dihydropyrazolo[1,5-a]pyrazin-4(5H)-ones as Cyclic Products of Beta-Amidomethyl Vinyl Sulfone Alphavirus Cysteine Protease Inhibitors